Copper is an essential trace mineral with a narrow useful range. Adding it helps mainly where a genuine shortfall exists, most often from high-dose zinc, weight-loss surgery or long-term acid suppression. Where copper status is already adequate, trials show no gain, and higher blood copper tracks with heart disease, death from any cause and the presence of Alzheimer's disease. (Full Review)

Protocol

Standard supplemental dose

1–2 mg daily

Elemental copper. Doses above 2 mg are reserved for documented deficiency under supervision.

Preferred forms

Bisglycinate or gluconate

Cupric oxide is poorly soluble and largely unabsorbed; copper sulfate is the most gastric-irritating form.

Best time of day

With a meal

Any consistent time; separated from zinc, iron, high-dose vitamin C and antacids.

Time to effect

Blood counts

4–12 weeks

Anemia, neutropenia and pancytopenia respond to repletion, typically within weeks to months.

Neurological recovery

Months

Where it occurs at all; usually incomplete, so repletion mainly stops further loss.

Benefits

Medium: Reversal of copper-deficiency anemia and neutropenia; arrest of copper-deficiency myelopathy

Low: Maintenance of bone mineral density; hepatic fat handling in low-copper states; glycemic control and type 2 diabetes risk; cognitive performance and decline; connective tissue and vascular elastic integrity

Speculative: Antioxidant enzyme capacity via Cu/Zn-superoxide dismutase; preservation of copper handling with age; skin and hair pigmentation support

Contraindications

Wilson disease (any confirmed ATP7B biallelic diagnosis, at any stage, treated or untreated)

Confirmed ATP7B carriers with non-ceruloplasmin copper above 1.6 µmol/L

Idiopathic copper toxicosis and Indian childhood cirrhosis

Cholestatic liver disease with bilirubin above 2 mg/dL (primary biliary cholangitis, primary sclerosing cholangitis)

Decompensated cirrhosis (Child-Pugh Class C)

Confirmed copper excess on testing (serum copper above 155 µg/dL or 24-hour urinary copper above 100 µg outside an acute-phase response)

Copper-chelating drugs (penicillamine, trientine, bis-choline tetrathiomolybdate)

Key Interactions

High-dose zinc (supplements, lozenges, denture adhesives; absolute contraindication above 50 mg daily without copper)

Iron supplements (ferrous sulfate, ferrous bisglycinate)

High-dose vitamin C (above 1,500 mg daily)

Molybdenum supplements

Proton pump inhibitors and H2 blockers (omeprazole, pantoprazole, famotidine)

Disulfiram and ammonium tetrathiomolybdate

Antacids and calcium carbonate

Supplements with additive copper load (multivitamins, bone, vision and greens formulas)

Risk & Side Effects

High: Acute gastrointestinal irritation from soluble copper

Medium: Higher copper status and cardiovascular and all-cause mortality; copper excess in Alzheimer's disease

Low: Liver injury with sustained high intake in susceptible individuals; suppression of zinc status; elevated copper-to-zinc ratio in cancer; raised copper in heart failure

Speculative: Cuproptosis-mediated mitochondrial proteotoxic stress; pro-oxidant damage from inorganic copper

Monitoring

Marker	Target	Why
Serum copper	90–120 µg/dL	Primary status marker
Ceruloplasmin	20–35 mg/dL	The functional copper carrier; falls in true deficiency
Non-ceruloplasmin copper	Below 10 µg/dL	The loosely bound fraction that carries the neurodegeneration association
Serum zinc	90–120 µg/dL	Copper's main antagonist; sets the dosing ratio
Copper-to-zinc ratio	0.7–1.0	Balance marker used by integrative practitioners
Hemoglobin	13.5–15.5 g/dL in women, 14.0–16.0 g/dL in men	Earliest objective sign of copper deficiency
Absolute neutrophil count	2.0–5.0 × 10⁹/L	Neutropenia often precedes anemia in copper deficiency
Ferritin and transferrin saturation	Ferritin 50–100 ng/mL; saturation 25–35%	Ceruloplasmin loads iron onto its transport protein, so copper deficiency mimics iron deficiency
ALT and AST	Below 25 U/L in women, below 30 U/L in men	Detects the rare hepatic response to sustained copper excess
24-hour urinary copper	Below 40 µg per 24 hours	Distinguishes genuine overload from an inflated serum reading
High-sensitivity C-reactive protein (hs-CRP)	Below 1.0 mg/L	Tells whether a high copper value reflects stores or inflammation
Vitamin B12	500–900 pg/mL	Produces a myelopathy indistinguishable from copper deficiency and often coexists with it

Cadence: Baseline panel before any change; copper panel and blood count repeated at 8 weeks after supplemental copper is started or stopped, again at 6 months, then every 12 months while intake continues. Intakes above 40 mg of supplemental zinc daily warrant the same schedule.

Qualitative Assessment

Gait steadiness and balance in the dark, which degrades early in copper-deficiency myelopathy
Tingling or numbness in the feet and hands, typically ascending and symmetrical
Frequency and duration of infections, a proxy for neutrophil adequacy
Energy and exercise tolerance, reflecting both anemia and mitochondrial copper enzymes
Loss of pigment in hair and skin, a late sign of severe deficiency
Gastrointestinal tolerance of the dose taken; nausea within an hour signals the dose or form needs changing

Copper for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment